FDA offers guidance on financial disclosures under Sunshine Act

03/7/2013 | MassDevice.com (Boston)

The FDA has issued draft guidance governing financial disclosures mandated by the Sunshine Act, which will go into effect Aug. 1. The document explains how manufacturers should report financial ties with doctors when applying for FDA marketing approval, which of those relationships should be reported and how bias is established.

View Full Article in:

MassDevice.com (Boston)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX